You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 41 No. 8, August 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Benzodiazepine Receptor—Mediated Model of Anxiety

Studies in Nonhuman Primates and Clinical Implications

Thomas R. Insel, MD; Philip T. Ninan, MD; Joseph Aloi; David C. Jimerson, MD; Phil Skolnick, PhD; Steven M. Paul, MD

Arch Gen Psychiatry. 1984;41(8):741-750.


Abstract

• β-Carboline-3-carboxylic acid ethyl ester (β-CCE) binds with high affinity to brain benzodiazepine receptors and has potent behavioral and physiologic effects in primates. Doserelated increases in behavioral agitation, plasma cortisol level, BP, and heart rate were observed after administration of doses between 50 and 500 µg/kg of β-CCE to rhesus monkeys. All of these effects were blocked by pretreatment with diazepam. Pretreatment with clonidine hydrochloride and propranolol hydrochloride, both of which have been reported to have anxiolytic actions in man, attenuated only selective aspects of the response to β-CCE. The behavioral, endocrine, and physiologic effects of low doses of β-CCE in monkeys are similar to those observed in anxious patients or normal subjects under anxiety-provoking or stressful situations. Administration of benzodiazepine receptor active antagonists such as β-CCE to primates may, therefore, provide a valid and reproducible model of human anxiety that could be used to investigate specific biologic aspects of anxiety disorders.



Author Affiliations

From the Clinical Neuropharmacology Branch (Dr Insel and Mr Aloi), the Laboratory of Clinical Science (Dr Jimerson), and the Clinical Neuroscience Branch (Dr Paul), National Institute of Mental Health; the Laboratory of Biorganic Chemistry (Dr Skolnick), National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases, Bethesda, Md; and the Department of Psychiatry (Dr Ninan), Emory University and Veterans Administration Hospital, Atlanta.


Footnotes

Accepted for publication Dec 26, 1983.

Reprint requests to Clinical Neuropharmacology Branch, National Institutes of Health Clinical Center 10-3D 41, Bethesda, MD 20205 (Dr Insel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cortisol and Sodium Lactate--Induced Panic
Hollander et al.
Arch Gen Psychiatry 1989;46:135-140.
ABSTRACT  

Behavioral and Physiologic Effects of Short-term and Long-term Administration of Clonidine in Panic Disorder
Uhde et al.
Arch Gen Psychiatry 1989;46:170-177.
ABSTRACT  

Behavioral Inhibition in Children of Parents With Panic Disorder and Agoraphobia: A Controlled Study
Rosenbaum et al.
Arch Gen Psychiatry 1988;45:463-470.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.